Fulminant type 1 diabetes mellitus in pregnancy

Detalhes bibliográficos
Autor(a) principal: Li,Chun-Yu
Data de Publicação: 2020
Outros Autores: Li,Yang, You,Zi-Ying, Liu,You-Ren, Wang,Yu-Jue, Mu,Tong, Zhao,Cheng-Zhi, Yi,Zu-Mu, Zhang,Yu-Wei
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000900501
Resumo: Fulminant type 1 diabetes mellitus (FT1DM) has received clinical attention for its low incidence and poor prognosis. Currently, few cases of FT1DM are associated with pregnancy in clinical practice, but it poses a great threat to the life of mothers and infants. Here, we present two cases of FT1DM in pregnancy. In Case 1, the patient was a 26-year-old woman who was admitted to the hospital with reduced fetal movement. She was diagnosed with FT1DM and delivered a dead female fetus. Lispro and lantus were administered to control blood glucose, and lipoic acid for antioxidant therapy. In Case 2, the patient was a 28-year-old woman who developed nausea, vomiting, diarrhea, and polydipsia, which later proved to be FT1DM. An abortion was induced and blood glucose levels were controlled using an insulin pump. All physicians should be aware of this disease in order to provide prompt diagnosis and emergency treatment, thus improving maternal prognosis. We suggest that plasma glucose/hemoglobin A1C ratio be adopted as a new clinical parameter in predicting FT1DM.
id ABDC-1_dd7f3913fbbffe495b880998caa4ce55
oai_identifier_str oai:scielo:S0100-879X2020000900501
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Fulminant type 1 diabetes mellitus in pregnancyFulminant type 1 diabetes mellitusPregnancyDiabetic ketoacidosisPlasma glucoseHemoglobin A1CFulminant type 1 diabetes mellitus (FT1DM) has received clinical attention for its low incidence and poor prognosis. Currently, few cases of FT1DM are associated with pregnancy in clinical practice, but it poses a great threat to the life of mothers and infants. Here, we present two cases of FT1DM in pregnancy. In Case 1, the patient was a 26-year-old woman who was admitted to the hospital with reduced fetal movement. She was diagnosed with FT1DM and delivered a dead female fetus. Lispro and lantus were administered to control blood glucose, and lipoic acid for antioxidant therapy. In Case 2, the patient was a 28-year-old woman who developed nausea, vomiting, diarrhea, and polydipsia, which later proved to be FT1DM. An abortion was induced and blood glucose levels were controlled using an insulin pump. All physicians should be aware of this disease in order to provide prompt diagnosis and emergency treatment, thus improving maternal prognosis. We suggest that plasma glucose/hemoglobin A1C ratio be adopted as a new clinical parameter in predicting FT1DM.Associação Brasileira de Divulgação Científica2020-01-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000900501Brazilian Journal of Medical and Biological Research v.53 n.9 2020reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20209633info:eu-repo/semantics/openAccessLi,Chun-YuLi,YangYou,Zi-YingLiu,You-RenWang,Yu-JueMu,TongZhao,Cheng-ZhiYi,Zu-MuZhang,Yu-Weieng2020-07-14T00:00:00Zoai:scielo:S0100-879X2020000900501Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2020-07-14T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Fulminant type 1 diabetes mellitus in pregnancy
title Fulminant type 1 diabetes mellitus in pregnancy
spellingShingle Fulminant type 1 diabetes mellitus in pregnancy
Li,Chun-Yu
Fulminant type 1 diabetes mellitus
Pregnancy
Diabetic ketoacidosis
Plasma glucose
Hemoglobin A1C
title_short Fulminant type 1 diabetes mellitus in pregnancy
title_full Fulminant type 1 diabetes mellitus in pregnancy
title_fullStr Fulminant type 1 diabetes mellitus in pregnancy
title_full_unstemmed Fulminant type 1 diabetes mellitus in pregnancy
title_sort Fulminant type 1 diabetes mellitus in pregnancy
author Li,Chun-Yu
author_facet Li,Chun-Yu
Li,Yang
You,Zi-Ying
Liu,You-Ren
Wang,Yu-Jue
Mu,Tong
Zhao,Cheng-Zhi
Yi,Zu-Mu
Zhang,Yu-Wei
author_role author
author2 Li,Yang
You,Zi-Ying
Liu,You-Ren
Wang,Yu-Jue
Mu,Tong
Zhao,Cheng-Zhi
Yi,Zu-Mu
Zhang,Yu-Wei
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Li,Chun-Yu
Li,Yang
You,Zi-Ying
Liu,You-Ren
Wang,Yu-Jue
Mu,Tong
Zhao,Cheng-Zhi
Yi,Zu-Mu
Zhang,Yu-Wei
dc.subject.por.fl_str_mv Fulminant type 1 diabetes mellitus
Pregnancy
Diabetic ketoacidosis
Plasma glucose
Hemoglobin A1C
topic Fulminant type 1 diabetes mellitus
Pregnancy
Diabetic ketoacidosis
Plasma glucose
Hemoglobin A1C
description Fulminant type 1 diabetes mellitus (FT1DM) has received clinical attention for its low incidence and poor prognosis. Currently, few cases of FT1DM are associated with pregnancy in clinical practice, but it poses a great threat to the life of mothers and infants. Here, we present two cases of FT1DM in pregnancy. In Case 1, the patient was a 26-year-old woman who was admitted to the hospital with reduced fetal movement. She was diagnosed with FT1DM and delivered a dead female fetus. Lispro and lantus were administered to control blood glucose, and lipoic acid for antioxidant therapy. In Case 2, the patient was a 28-year-old woman who developed nausea, vomiting, diarrhea, and polydipsia, which later proved to be FT1DM. An abortion was induced and blood glucose levels were controlled using an insulin pump. All physicians should be aware of this disease in order to provide prompt diagnosis and emergency treatment, thus improving maternal prognosis. We suggest that plasma glucose/hemoglobin A1C ratio be adopted as a new clinical parameter in predicting FT1DM.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000900501
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000900501
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20209633
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.53 n.9 2020
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302947931455488